VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $207,000 | -28.9% | 7,575 | 0.0% | 0.01% | -20.0% |
| Q1 2022 | $291,000 | +19.8% | 7,575 | 0.0% | 0.01% | +11.1% |
| Q4 2021 | $243,000 | +9.0% | 7,575 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $223,000 | -13.2% | 7,575 | 0.0% | 0.01% | -10.0% |
| Q2 2021 | $257,000 | +4.5% | 7,575 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $246,000 | -9.9% | 7,575 | 0.0% | 0.01% | -23.1% |
| Q4 2020 | $273,000 | -8.1% | 7,575 | 0.0% | 0.01% | -13.3% |
| Q3 2020 | $297,000 | +6.8% | 7,575 | 0.0% | 0.02% | +7.1% |
| Q2 2020 | $278,000 | +25.2% | 7,575 | 0.0% | 0.01% | +75.0% |
| Q4 2019 | $222,000 | +9.9% | 7,575 | 0.0% | 0.01% | +14.3% |
| Q3 2019 | $202,000 | -3.8% | 7,575 | -17.3% | 0.01% | 0.0% |
| Q3 2017 | $210,000 | +4.0% | 9,160 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $202,000 | -8.2% | 9,160 | -5.2% | 0.01% | 0.0% |
| Q1 2017 | $220,000 | +8.9% | 9,660 | 0.0% | 0.01% | +16.7% |
| Q4 2016 | $202,000 | – | 9,660 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |